Publication Date

All

Current year

Past 5 years

 


 

Subject Area
Health (72)
See all

Results in Health from the past 5 years


72 results

Sort by date / relevance

The 2026-27 Budget: Medi-Cal Analysis

Mar 2, 2026 - More frequent renewals will likely increase the risk of disenrollment even among otherwise eligible individuals, due to the increased frequency of needing to submit required documentation. Like community engagement requirements, more frequent renewals are also expected to increase administrative workload for county eligibility systems, at least in the short run.
https://lao.ca.gov/Publications/Report/5146

The 2026-27 Budget: Medi-Cal Fiscal Outlook

Nov 19, 2025 - The policy likely bars Planned Parenthood from drawing down federal funds. Other providers could be affected too. This policy has already placed some budget pressure on the state to help backfill the lost federal funding.
https://lao.ca.gov/Publications/Report/5092

The 2025-26 Budget: CalAIM Enhanced Care Management and Community Supports Implementation Update

Mar 6, 2025 - Services to Enable Members to Remain in a Home ‑Like Setting Day habilitation programs Programs provided to assist beneficiaries with developing skills necessary to reside in home ‑like settings, often provided by peer mentor ‑type caregivers.
https://lao.ca.gov/Publications/Report/5003

The 2026-27 Budget: Department of Developmental Services

Mar 13, 2026 - In such cases, the consumer would likely need to wait until a provider is available before they can receive the authorized service. Actual utilization can therefore be lower than authorized utilization.
https://lao.ca.gov/Publications/Report/5157

Considering Medi-Cal in the Midst of a Changing Fiscal and Policy Landscape

Oct 24, 2025 - As such, the Legislature likely will want to better understand the needed changes, the time line for DHCS to adopt these changes, and the potential to offset some of these costs using enhanced federal funding.
https://lao.ca.gov/Publications/Report/5083

The 2025-26 Budget: Medi-Cal Pharmacy Spending

Apr 3, 2025 - Different Brands Treat Obesity and Diabetes Glucon ‑Like Peptide ‑1 (GLP ‑1) Agonists Drug
https://lao.ca.gov/Publications/Report/5026

The 2021-22 Budget: Analysis of the Medi-Cal Budget

Feb 16, 2021 - Although why employment losses have not yet had a significant impact on Medi ‑Cal caseload is unclear, there likely are several factors at play. For example, employment losses disproportionately have affected low ‑wage workers who were more likely to already be enrolled in Medi ‑Cal.
https://lao.ca.gov/Publications/Report/4373

The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - As of our analysis, however, HCAI indicated that it could not provide an estimated time line to receive federal approval to sell  the product. Naloxone Initiative Appears to Be Moving at Faster Pace.
https://lao.ca.gov/Publications/Report/4979

The 2025-26 California Spending Plan: Health

Oct 16, 2025 - Most notably, the administration plans to end coverage of Glucagon-Like Peptide-1 (GLP-1) agonists used to treat obesity (such as Wegovy). (Medi-Cal will still cover GLP-1s that treat diabetes, such as Ozempic, as required under federal law.)
https://lao.ca.gov/Publications/Report/5075

The 2025-26 Budget: Medi-Cal Fiscal Outlook

Nov 20, 2024 - Given that these augmentations will be new, the Legislature likely will want to track how they are structured and implemented. Moreover, the Legislature could consider which, if any, of its previously enacted augmentations it would like to support from the General Fund.
https://lao.ca.gov/Publications/Report/4941